Medela, a global healthcare company known for its breastfeeding brand, announced it will transition its wound care business into a separate global company. This new standalone wound care company will continue to provide wound care solutions powered by Medela’s medical vacuum technology including Medela’s Negative Pressure Wound Therapy (NPWT) line of products and services.
Chronic, non-healing wounds are a global public health challenge associated with significant physical and economic burdens for patients and health care systems. Common types of wounds include pressure injuries, diabetic foot ulcers, arterial and venous insufficiency ulcers, traumatic wounds, burns, and post-surgical incisions, among others. Medela’s technologies such as Intelligent Pressure Control and Dynamic Exudate Removal technology in Invia systems provide NPWT solutions and can help heal complex wounds more effectively, reducing healing time, and improving quality of life for patients.
Further Reading: Researchers Develop Smart Bandage for Chronic Wounds
The new standalone company will also incorporate the latest technology in wound therapy from medaxis, to provide unique solutions to advance healing and improve health outcomes. The medaxis technology helps support neovascularization and tissue growth, increases cellular activity and circulation, and supports bacterial load reduction. Earning an FDA Breakthrough Designation, the medaxis technology will provide the new wound care company with a comprehensive approach to wound healing backed by a strong business model and expansive network to help more healthcare professionals and patients. Medaxis is a Swiss medical technology company that is a part of Olle Larsson Holding (OLH).
Effective December 1, Jeff Castillo will transition from executive vice president of Medela Americas to lead the new wound care company as CEO. Prior to his role at Medela, Castillo served in several medical device leadership positions, including at Johnson and Johnson (J&J), Abbott, and Merz.
Further Reading: Adding Wound Care Specialist to Proning Team Helps Reduce Pressure Injury Risks
“I am honored and excited to lead the new wound care company,” says Castillo. “Medela has a long legacy driven by exceptional medical vacuum technology. I look forward to working alongside these dedicated professionals to set new standards of care with wound care solutions powered by Medela’s medical vacuum technology and new medical innovations from medaxis.”
The new wound care company will continue to utilize Medela’s Elgin, Ill., facility for shipping products. Current medaxis employees and leadership as well as existing Medela wound care team members will transition under the leadership of Jeff Castillo as of December 1. According to the company, Medela is dedicated to ensuring a seamless transition for customers to the new wound care company.
